Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03579563 · ClinicalTrials.gov registry record · NA
Impact of Hearing Aid Service-delivery Model and Technology on Patient Outcomes
A NA study, sponsored by Yu-Hsiang Wu.
- Completed
- Registry status
- NA
- Development phase
- 290
- Enrollment target
NCT03579563 is a NA study that has completed, run by Yu-Hsiang Wu. The registered enrollment target is 290 participants.
The verdict
NCT03579563, a NA study, has completed, sponsored by Yu-Hsiang Wu.
- COMPLETED
- Registry status
- NA
- Development phase
- 290 participants
- Enrollment target
Study Summary
Age-related hearing loss is a big problem in the United States because many people have it and it affects their quality of life. Hearing aids can help, but not many people use them. One reason is that getting hearing aids can be expensive and difficult. People usually have to visit doctors, like audiologists, many times to get their hearing tested and have the hearing aids fitted and adjusted. This process is called the AUD service model in this study. Hearing aids come with different technologies and features, like directional microphones and noise reduction algorithms. These features can make hearing aids work better but also make them more expensive, which can be another barrier for people who need them. Recently, over-the-counter (OTC) hearing aids have become available. These hearing aids are cheaper and easier to get because people can buy them directly and fit them on their own without seeing a doctor. This is called the OTC service model in this study. Another service model that could be great is a "hybrid" service model, where professionals help fit the OTC hearing aids. This hybrid model can make hearing aids both affordable and high quality. Studies have shown that the OTC service model works as well as the AUD service model. Additionally, other research has found no big differences in how well high-end and low-end hearing aids work for patients. However, no one has studied the different service models and technology levels together in one study, and no one has looked at how well the hybrid service model (called the OTC+ service model in this study) works. The goal of this study is to find out how the different ways of fitting hearing aids (AUD, OTC+, and OTC) and the different technology levels (high-end and low-end) affect patient outcomes. The study will take place at two sites and will be a randomized controlled trial. Participants will be randomly assigned to one of six groups, which are combinations of the three service models and two technology
Interventions
- OTHER AUD fitting
- OTHER OTC+ fitting
- OTHER OTC fitting
- DEVICE High-end HA
- DEVICE Low-end HA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 290 participants |
| Start Date | 2019-02-22 |
| Est. Completion | 2023-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03579563
The ClinicalTrials.gov registry entry for NCT03579563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yu-Hsiang Wu, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which AUD fitting is the first listed.
NCT03579563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03579563 about?
NCT03579563 is a clinical study titled "Impact of Hearing Aid Service-delivery Model and Technology on Patient Outcomes". Age-related hearing loss is a big problem in the United States because many people have it and it affects their quality of life. Hearing aids can help, but not many people use them. One reason is that getting hearing aids can be expensive and difficult. People usually have to visit doctors, like aud...
What is the current status of trial NCT03579563?
This trial is currently completed. It is a NA study. The enrollment target is 290 participants. The study started on 2019-02-22. Estimated completion is 2023-12-22.
What interventions are being tested in trial NCT03579563?
The interventions under investigation include: AUD fitting (OTHER), OTC+ fitting (OTHER), OTC fitting (OTHER), High-end HA (DEVICE), Low-end HA (DEVICE).
Who is sponsoring clinical trial NCT03579563?
This trial is sponsored by Yu-Hsiang Wu, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.